Literature DB >> 33583610

The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail.

Benjamin A Howell1, Lisa Puglisi1, Katie Clark2, Carmen Albizu-Garcia3, Evan Ashkin4, Tyler Booth5, Lauren Brinkley-Rubinstein4, David A Fiellin6, Aaron D Fox7, Kathleen F Maurer8, Hsiu-Ju Lin9, Kathryn McCollister10, Sean Murphy11, Diane S Morse12, Shira Shavit13, Karen Wang14, Tyler Winkelman15, Emily A Wang16.   

Abstract

BACKGROUND: In 2016, at least 20% of people with opioid use disorder (OUD) were involved in the criminal justice system, with the majority of individuals cycling through jails. Opioid overdose is the leading cause of death and a common cause of morbidity after release from incarceration. Medications for OUD (MOUD) are effective at reducing overdoses, but few interventions have successfully engaged and retained individuals after release from incarceration in treatment.
OBJECTIVE: To assess whether follow-up care in the Transitions Clinic Network (TCN), which provides OUD treatment and enhanced primary care for people released from incarceration, improves key measures in the opioid treatment cascade after release from jail. In TCN programs, primary care teams include a community health worker with a history of incarceration, and they attend to social needs, such as housing, food insecurity, and criminal legal system contact, along with patients' medical needs. METHODS AND ANALYSIS: We will bring together six correctional systems and community health centers with TCN programs to conduct a hybrid type-1 effectiveness/implementation study among individuals who were released from jail on MOUD. We will randomize 800 individuals on MOUD released from seven local jails (Bridgeport, CT; Niantic, CT; Bronx, NY; Caguas, PR; Durham, NC; Minneapolis, MN; Ontario County, NY) to compare the effectiveness of a TCN intervention versus referral to standard primary care to improve measures within the opioid treatment cascade. We will also determine what social determinants of health are mediating any observed associations between assignment to the TCN program and opioid treatment cascade measures. Last, we will study the cost effectiveness of the approach, as well as individual, organizational, and policy-level barriers and facilitators to successfully transitioning individuals on MOUD from jail to the TCN. ETHICS AND DISSEMINATION: Investigation Review Board the University of North Carolina (IRB Study # 19-1713), the Office of Human Research Protections, and the NIDA JCOIN Data Safety Monitoring Board approved the study. We will disseminate study findings through peer-reviewed publications and academic and community presentations. We will disseminate study data through a web-based platform designed to share data with TCN PATHS participants and other TCN stakeholders. Clinical trials.gov registration: NCT04309565.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Incarceration; Medications for opioid-use disorders (MOUD); Opioid-use disorders; Primary health care; Re-entry

Mesh:

Year:  2021        PMID: 33583610      PMCID: PMC8319218          DOI: 10.1016/j.jsat.2021.108315

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  36 in total

1.  The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people.

Authors:  L Gelberg; R M Andersen; B D Leake
Journal:  Health Serv Res       Date:  2000-02       Impact factor: 3.402

2.  Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial.

Authors:  David A Wohl; Anna Scheyett; Carol E Golin; Becky White; Jeanine Matuszewski; Michael Bowling; Paula Smith; Faye Duffin; David Rosen; Andrew Kaplan; JoAnne Earp
Journal:  AIDS Behav       Date:  2011-02

3.  Death After Jail Release.

Authors:  Byron Alex; David B Weiss; Fatos Kaba; Zachary Rosner; David Lee; Sungwoo Lim; Homer Venters; Ross MacDonald
Journal:  J Correct Health Care       Date:  2017-01-01

4.  Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.

Authors:  Jeannia J Fu; Nickolas D Zaller; Michael A Yokell; Alexander R Bazazi; Josiah D Rich
Journal:  J Subst Abuse Treat       Date:  2013-02-22

5.  National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.

Authors:  Christopher M Jones; Melinda Campopiano; Grant Baldwin; Elinore McCance-Katz
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

6.  Community reentry: perceptions of people with substance use problems returning home from New York City jails.

Authors:  Juliana van Olphen; Nicholas Freudenberg; Princess Fortin; Sandro Galea
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

7.  Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.

Authors:  Peter J Neumann; Joshua T Cohen; Milton C Weinstein
Journal:  N Engl J Med       Date:  2014-08-28       Impact factor: 91.245

8.  Does a Primary Health Clinic for Formerly Incarcerated Women Increase Linkage to Care?

Authors:  Diane S Morse; John L Wilson; James M McMahon; Ann M Dozier; Anabel Quiroz; Catherine Cerulli
Journal:  Womens Health Issues       Date:  2017-03-13

9.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.

Authors:  Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

10.  Risks of drug-related death, suicide, and homicide during the immediate post-release period among people released from New York City jails, 2001-2005.

Authors:  Sungwoo Lim; Amber Levanon Seligson; Farah M Parvez; Charles W Luther; Maushumi P Mavinkurve; Ingrid A Binswanger; Bonnie D Kerker
Journal:  Am J Epidemiol       Date:  2012-02-13       Impact factor: 4.897

View more
  4 in total

1.  Health economic analyses of the justice community opioid innovation network (JCOIN).

Authors:  Sean M Murphy; Neda Laiteerapong; Mai T Pho; Danielle Ryan; Iván Montoya; Theresa I Shireman; Elbert Huang; Kathryn E McCollister
Journal:  J Subst Abuse Treat       Date:  2021-01-06

2.  Healthcare beliefs, health information seeking, and healthcare setting preferences among women who inject drugs by community supervision status.

Authors:  Ariel Hoadley; Sarah Bauerle Bass; Jesse Brujaha; Paul A D'Avanzo; Patrick J Kelly
Journal:  Health Justice       Date:  2021-04-16

3.  Role of the Intersections of Gender, Race and Sexual Orientation in the Association between Substance Use Behaviors and Sexually Transmitted Infections in a National Sample of Adults with Recent Criminal Legal Involvement.

Authors:  Tyler D Harvey; Ijeoma Opara; Emily A Wang
Journal:  Int J Environ Res Public Health       Date:  2022-03-30       Impact factor: 3.390

4.  Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada.

Authors:  Cayley Russell; Michelle Pang; Frishta Nafeh; Shanna Farrell Macdonald; Dena Derkzen; Jürgen Rehm; Benedikt Fischer
Journal:  Int J Qual Stud Health Well-being       Date:  2022-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.